Diabetes Mellitus, Non-Insulin-Dependent Clinical Trial
Official title:
Tissue Distribution of F18-FDG Labeled Autologous Bone Marrow Derived Stem Cells in Patients With Type2 Diabetes Mellitus
Stem cells have promising potential in treating diabetes. However the therapeutic outcome in diabetic patients will profoundly depend on their delivery to pancreas. Our objective is to label stem cells with PET tracer F18-FDG to carry out in vivo cell tracking. The labeled stem cells will be given through different routes (intravenous and intraarterial)and tissue distribution studied. Patients will be followed up for the next 6 months. Glucagon stimulated C peptide will be measured at baseline and at 6 months and HOMA IR and HOMA beta will be calculated.
Our objective is to label stem cells with PET tracer F18-FDG to carry out in vivo cell tracking. The labeled stem cells will be given through different routes (intravenous and intraarterial)and tissue distribution studied. Patients will be followed up for the next 6 months. Glucagon stimulated C peptide will be measured at baseline and at 6 months and HOMA IR and HOMA beta will be calculated. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02801448 -
Clinical Trial With Broccoli Sprout Extract to Patients With Type 2 Diabetes
|
Phase 2 | |
| Withdrawn |
NCT01377961 -
Effect of Lycopene and Isoflavones on Glucose Metabolism
|
N/A | |
| Completed |
NCT00754130 -
MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).
|
Phase 1 | |
| Completed |
NCT00006305 -
Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT00004983 -
Education and Group Support for Diabetic Hispanics
|
N/A | |
| Completed |
NCT00010751 -
Effects of Reiki on Painful Neuropathy and Cardiovascular Risk Factors
|
Phase 2 | |
| Completed |
NCT02299388 -
To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study
|
Phase 4 | |
| Completed |
NCT00550329 -
Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets
|
Phase 1 | |
| Completed |
NCT00172536 -
Effects of Exercise Training on Left Ventricular Function in Type 2 Diabetic Patients Post Coronary Artery Bypass Graft
|
N/A | |
| Completed |
NCT00071422 -
Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes
|
Phase 2 | |
| Completed |
NCT00029848 -
Obese Patients With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT01694758 -
OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA
|
N/A | |
| Completed |
NCT01608724 -
The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT00979368 -
Safety Study of BMS-816336 in Healthy Male Subjects
|
Phase 1 | |
| Completed |
NCT00791661 -
MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005)
|
Phase 1 | |
| Active, not recruiting |
NCT02088658 -
Technology Intensified Diabetes Education Study in African Americans
|
N/A | |
| Completed |
NCT01105429 -
Single Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes
|
Phase 1 | |
| Completed |
NCT00701090 -
A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)
|
Phase 3 | |
| Completed |
NCT00952991 -
The Effects of LAF237 on Gastric Function in Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT00035984 -
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
|
Phase 3 |